LexisNexis® Legal Newsroom
Should Motivations Matter?

This article was reprinted with permission from FCPA Professor GlaxoSmithKline’s (GSK) scrutiny in China – by the Chinese government – dominated the headlines in July (see here for a prior post). Shortly thereafter, many began to question the motivations of the Chinese government...